Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7532

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

Atorvastatinfigure1 (Atorvastatinfigure1)
Chemical structure of atorvastatin calcium, shown as a dimer with calcium ion and three water molecules associated. The diagram depicts the molecular arrangement of the active ingredient atorvastatin calcium.*
FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
A line graph depicting cumulative incidence (%) over a period of 3.5 years, comparing Atorvastatin (solid line) with Placebo (dashed line). The graph shows higher cumulative incidence for Placebo compared to Atorvastatin. The graph includes a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
A line graph comparing cumulative hazard (%) over time in years for placebo and atorvastatin groups through four years of follow-up. The placebo group is shown with a dashed line and the atorvastatin group with a solid line. The graph includes a hazard ratio (HR) of 0.63 with a 95% confidence interval (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
A line graph depicting the percentage of subjects experiencing the first major cardiovascular endpoint over time (years) for two Atorvastatin dosage groups: 10 mg and 80 mg. The graph shows cumulative event rates on the vertical axis and years up to 5 on the horizontal axis, with a hazard ratio and p-value noted for comparison.*
FDA Label Image

Label Image (Lbl500907532)

Label Image (Lbl500907532)
Label for ATORVASTATIN CALCIUM 80 mg film-coated tablets by A-S Medication Solutions. The package contains 30 tablets. Storage instructions indicate keeping the product at 68 to 77 degrees Fahrenheit. The label includes the product's NDC 50090-7532.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.